The Pharmacotherapy Update 2021 is organized by AchieveCE.

Release Date: 04/11/2022
Expiration Date: 04/11/2028

Description:
The FDA has increased the number of medication approvals exponentially over the past 10 years. In 2020, 53 new drugs and biologics were approved as compared to 48 in 2019. Of the ones approved last year, 40% were first in class, and 58% received indications to manage rare diseases.

This CE addresses approximately 35 of the new medications approved in 2020 that the average pharmacist may not have had time to review and keep track of as they entered the market. This presentation will address this gap and focus on medications used primarily in the Ambulatory Care and Community practice settings. The information is centered not only on how the medications work but also includes clinical trial summaries that led to their approval by the FDA which will be discussed in relation to current EBM guidelines and treatment algorithms.

What you will learn:
At the conclusion of this continuing education activity, the participant will be able to:

Identify the new pharmaceutical agents available for clinical practice
Outline the use of new pharmaceutical agents in clinical practice
Explain the benefits, risks, and alternatives of new pharmaceutical agents